Molecular and clinical attributes of uterine leiomyomas
Open Access
- 15 June 2017
- journal article
- review article
- Published by SAGE Publications in Tumor Biology
- Vol. 39 (6)
Abstract
Uterine leiomyomas, also called uterine fibroids or myomas, represent one of the most common benign tumour types in women of a fertile age. Leiomyomas arise due to transformation of the layer of smooth muscle cells of corpus uteri – the myometrium. Despite frequent occurrence of this disease, the molecular mechanisms behind the origin and development of leiomyomas are still relatively unknown. Most predisposed are obese women and women of African origin. In more than half of cases, leiomyomas remain asymptomatic. Genetic factors also have an important impact on the development of these hormone-dependent tumours. However, the clinical and molecular characteristics of familiar and sporadic leiomyomas can widely differ. The main reason is the heterogeneity of this disease and the abundance of factors which can underlie their tumourigenesis. Clinical diagnosis of uterine leiomyomas without surgical interference can be hindered in the case of small, mostly submucosal leiomyomas or if it is necessary to avoid potential malignancy of tumour. Also, medical treatment of uterine leiomyomas cannot be nowadays considered sufficient with many medical agents still being tested only within clinical research. The main goal of this article is to summarise known facts about the aetiology of leiomyomas, risk factors that contribute to their development, known molecular-genetic aberrations connected with the presence of leiomyomas as well as the possibilities of their diagnosis and treatmentKeywords
This publication has 133 references indexed in Scilit:
- Genome-wide Linkage and Association Analyses Implicate FASN in Predisposition to Uterine LeiomyomataThe American Journal of Human Genetics, 2012
- The estimated annual cost of uterine leiomyomata in the United StatesAmerican Journal of Obstetrics and Gynecology, 2012
- Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implicationsHuman Reproduction Update, 2011
- Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferaseFertility and Sterility, 2011
- Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cellsFertility and Sterility, 2010
- Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude miceAmerican Journal of Obstetrics and Gynecology, 2010
- Growth of uterine leiomyomata among premenopausal black and white womenProceedings of the National Academy of Sciences, 2008
- The Expression and Potential Regulatory Function of MicroRNAs in the Pathogenesis of LeiomyomaSeminars in Reproductive Medicine, 2008
- Differential expression of microRNA species in human uterine leiomyoma versus normal myometriumFertility and Sterility, 2008
- Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroidsJournal of Cellular and Molecular Medicine, 2007